Our partners author several articles and analyses in science and industry journals.

Publications 2015

The journal Kemivärlden Biotech features an article on Ventac portfolio company, Idogen, highlighting the company’s work on the development of tolerogenic vaccines. To read the article (in Swedish), please follow this link.

Idogen’s CEO and partner in Ventac Partners, Lars Hedbys gives an interview in the Medicon Village newsletter discussing collaboration opportunities in the area. To read the article (in Swedish), please follow this link.

Laborjournal, a German life sciences journal publishes article of portfolio company, Miacom Diagonistics. A copy of the article is available here (in German).

Ventac Partner Kostas Alevizopoulos authors article entitled “How will specialty drugs affect the global healthcare industry in 2015?” To read the article, please follow this link.

Subscribe to our Newsletter

Thank you!